Rebecca Slack Tidwell

24PUBLICATIONS
183CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Apr 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma.

|Mar 30, 2026
Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability.

Mohammad Jad Moussa, Alexander Y Andreev-Drakhlin, Aradhana M Venkatesan

|Nov 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.

Melinda Soeung, Xinmiao Yan, Ciro Zanca

|Sep 12, 2025
Impact of Postpartum Diagnosis on Survival of Women with Inflammatory Breast Cancer.

Jennifer H Chen, Rebecca S Slack Tidwell, Megumi Kai

|Feb 21, 2025
Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial.

Sangeeta Goswami, Jianjun Gao, Sreyashi Basu

|Nov 28, 2024
Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinoma.

Sangeeta Goswami, Jianjun Gao, Sreyashi Basu

Pageof 4

Frequent Collaborators

7 joint publications

Padmanee Sharma

7 joint publications

Matthew T Campbell

7 joint publications

Sreyashi Basu

7 joint publications

Jianjun Gao